Uterine leiomyomas express myometrial contractile-associated proteins involved in pregnancy-related hormone signaling

Journal of the Society for Gynecologic Investigation

Volumn 10, Issue 1, 2003, Pages 11-20

  Cesen Cummings, Kimberley ^a,b,c   Houston, Kevin D ^a,b,c   Copland, John A ^a,b,c   Moorman, Valerie J ^a,b,c   Walker, Cheryl Lyn ^a,b,c   Davis, Barbara J ^a,b,c,d  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^d Mail Drop A2 01 ^*  (United States)

Author keywords

Leiomyoma; Myometrium; Oxytocin receptor; Parturition; Uterus

Indexed keywords

CONNEXIN 43; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ESTROGEN; OXYTOCIN; OXYTOCIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL LINE; CELL PROLIFERATION; CHILDBIRTH; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; MYOMETRIUM; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; TUMOR GROWTH; UTERUS MYOMA;

ANIMALS; BLOTTING, WESTERN; CELL DIVISION; CONNEXIN 43; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINOPROSTONE; ESTRADIOL; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; ISOENZYMES; LEIOMYOMA; MEMBRANE PROTEINS; MYOMETRIUM; OXYTOCIN; POLYMERASE CHAIN REACTION; PREGNANCY; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RECEPTORS, OXYTOCIN; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; UTERINE NEOPLASMS;

EID: 0037223278     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-5576(02)00191-0     Document Type: Article

References (49)

1. Marshall L.M., Spiegelman D., Barbieri R.L., et al. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol. 90:(6):1997;967-973.
2. Marshall L.M., Spiegelman D., Goldman M.B., et al. A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata. Fertil Steril. 70:(3):1998;432-439.
3. Ross RK, Pike MC, Vessey MP, Bull D, Yeates D, Casagrande JT. Risk factors for uterine fibroids: Reduced risk associated with oral contraceptives. BMJ 1986;293:359-62.
4. Lumbiganon P., Rugpao S., Phandhu-fung S., Laopaiboon M., Vudhikamraksa N., Werawatakul Y. Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas A multicentre case-control study . Br J Obstet Gynaecol. 103:(9):1996;909-914.
5. Walker C.L., Cesen-Cummings K., Houle C., Baird D., Barrett J.C., Davis B. Protective effect of pregnancy for the development of uterine leiomyoma. Carcinogenesis. 22:2001;2049-2052.
6. Cesen-Cummings K., Copland J.A., Barrett J.C., Walker C.L., Davis B.J. Pregnancy, parturition, and prostaglandins Defining uterine leiomyomas . Environ Health Perspect. 108:(Suppl 5):2000;817-820.
7. Wu W.X., Unno N., Ma X.H., Nathanielsz P.W. Inhibition of prostaglandin production by nimesulide is accompanied by changes in expression of the cassette of uterine labor-related genes in pregnant sheep. Endocrinology. 139:(7):1998;3096-3103.
8. Andersen J., Barbieri R.L. Abnormal gene expression in uterine leiomyomas. J Soc Gynecol Investig. 2:(5):1995;663-672.
9. Andersen J., Grine E., Eng C.L., et al. Expression of connexin-43 in human myometrium and leiomyoma. Am J Obstet Gynecol. 169:(5):1993;1266-1276.
10. Lee K.H., Khan-Dawood F.S., Dawood M.Y. Oxytocin receptor and its messenger ribonucleic acid in human leiomyoma and myometrium. Am J Obstet Gynecol. 179:(3 Pt 1):1998;620-627.
11. Hunter D.S., Hodges L.C., Eagon P.K., et al. Influence of exogenous estrogen receptor ligands on uterine leiomyoma Evidence from an in vitro/in vivo animal model for uterine fibroids . Environ Health Perspect. 108:(Suppl 5):2000;829-834.
12. Walker C.L., Burroughs K.D., Davis B., Sowell K., Everitt J.I., Fuchs-Young R. Preclinical evidence for therapeutic efficacy of selective estrogen receptor modulators for uterine leiomyoma. J Soc Gynecol Investig. 7:(4):2000;249-256.
13. Howe S.R., Gottardis M.M., Everitt J.I., Goldsworthy T.L., Wolf D.C., Walker C. Rodent model of reproductive tract leiomyomata. Establishment and characterization of tumor-derived cell lines. Am J Pathol. 146:(6):1995;1568-1579.
14. Howe S.R., Gottardis M.M., Everitt J.I., Walker C. Estrogen stimulation and tamoxifen inhibition of leiomyoma cell growth in vitro and in vivo. Endocrinology. 136:(11):1995;4996-5003.
15. Slater D., Berger L., Newton R., Moore G., Bennett P. The relative abundance of type 1 to type 2 cyclo-oxygenase mRNA in human amnion at term. Biochem Biophys Res Commun. 198:(1):1994;304-308.
16. Dong Y.L., Gangula P.R., Fang L., Yallampalli C. Differential expression of cyclooxygenase-1 and -2 proteins in rat uterus and cervix during the estrous cycle, pregnancy, labor and in myometrial cells. Prostaglandins. 52:(1):1996;13-34.
17. Chirgwin J.M., Pryzbyla A.E., MacDonald R.J., Rutter W. Isolation of biologically active ribonucleic acid from sources rich in ribonuclease. Biochemistry. 18:1979;5294-5299.
18. Hinko A., Soloff M.S. Characterization of oxytocin receptors in rabbit amnion involved in the production of prostaglandin E2. Endocrinology. 130:(6):1992;3547-3553.
19. Grynkiewicz G., Poenie M., Tsien R.Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 260:(6):1985;3440-3450.
20. Cassoni P., Sapino A., Fortunati N., Munaron L., Chini B., Bussolati G. Oxytocin inhibits the proliferation of MDA-MB231 human breast-cancer cells via cyclic adenosine monophosphate and protein kinase A. Int J Cancer. 72:(2):1997;340-344.
21. Draeger A., Graf A.H., Staudach A., North A.J., Small J.V. Smooth muscle differentiation in human myometrium and uterine leiomyoma. Virchows Arch B Cell Pathol Incl Mol Pathol. 64:(1):1993;21-27.
22. Nathanielsz P.W. Endocrine mechanisms of parturition. Annu Rev Physiol. 40:1978;411-445.
23. Challis J.R.G., Mitchell B.F. Endocrinology of pregnancy and parturition. Warshaw J.B. The Biological Basis of Reproductive and Developmental Medicine. 1983;85-131 Elsevier Biomedical, New York.
24. Zuo J., Lei Z.M., Rao C.V., Pietrantoni M., Cook V.D. Differential cyclooxygenase-1 and -2 gene expression in human myometria from preterm and term deliveries. J Clin Endocrinol Metab. 79:(3):1994;894-899.
25. Slater D.M., Dennes W.J., Campa J.S., Poston L., Bennett P.R. Expression of cyclo-oxygenase types-1 and -2 in human myometrium throughout pregnancy. Mol Hum Reprod. 5:(9):1999;880-884.
26. Fang L., Chatterjee S., Dong Y.L., Gangula P.R., Yallampalli C. Immunohistochemical localization of constitutive and inducible cyclo-oxygenases in rat uterus during the oestrous cycle and pregnancy. Histochem J. 30:(6):1998;383-391.
27. Trifan O.C., Smith R.M., Thompson B.D., Hla T. Overexpression of cyclooxygenase-2 induces cell cycle arrest. Evidence for a prostaglandin-independent mechanism. J Biol Chem. 274:(48):1999;34141-34147.
28. Burroughs K.D., Fuchs-Young R., Davis B., Walker C.L. Altered hormonal responsiveness of proliferation and apoptosis during myometrial maturation and the development of uterine leiomyomas in the rat. Biol Reprod. 63:(5):2000;1322-1330.
29. Fuchs A.R., Fuchs F., Husslein P., Soloff M.S., Fernstrom M.J. Oxytocin receptors and human parturition A dual role for oxytocin in the initiation of labor . Science. 215:(4538):1982;1396-1398.
30. Fuchs A.R., Periyasamy S., Alexandrova M., Soloff M.S. Correlation between oxytocin receptor concentration and responsiveness to oxytocin in pregnant rat myometrium Effects of ovarian steroids . Endocrinology. 113:(2):1983;742-749.
31. Kimura T., Takemura M., Nomura S., et al. Expression of oxytocin receptor in human pregnant myometrium. Endocrinology. 137:(2):1996;780-785.
32. Adachi S., Oku M. The regulation of oxytocin receptor expression in human myometrial monolayer culture. J Smooth Muscle Res. 31:(4):1995;175-187.
33. Zingg H.H., Rozen F., Breton C., et al. Gonadal steroid regulation of oxytocin and oxytocin receptor gene expression. Adv Exp Med Biol. 395:1995;395-404.
34. Cassoni P., Sapino A., Negro F., Bussolati G. Oxytocin inhibits proliferation of human breast cancer cell lines. Virchows Arch. 425:(5):1994;467-472.
35. Cassoni P., Sapino A., Papotti M., Bussolati G. Oxytocin and oxytocin-analogue F314 inhibit cell proliferation and tumor growth of rat and mouse mammary carcinomas. Int J Cancer. 66:(6):1996;817-820.
36. Strakova Z., Soloff M.S. Coupling of oxytocin receptor to G proteins in rat myometrium during labor Gi receptor interaction . Am J Physiol. 272:(5 Part 1):1997;E870-E876.
37. Hoare S., Copland J.A., Strakova Z., et al. The proximal portion of the COOH terminus of the oxytocin receptor is required for coupling to g(q), but not g(i). Independent mechanisms for elevating intracellular calcium concentrations from intracellular stores. J Biol Chem. 274:1999;28682-28689.
38. Soloff M.S., Jeng Y.J., Copland J.A., Strakova Z., Hoare S. Signal pathways mediating oxytocin stimulation of prostaglandin synthesis in select target cells. Exp Physiol. 85:(Suppl):2000;51S-58S.
39. Ambrus G., Rao C.V. Novel regulation of pregnant human myometrial smooth muscle cell gap junctions by human chorionic gonadotropin. Endocrinology. 135:1994;2772-2779.
40. Garfield R., Sims S., Daniel E. Gap junctions Their presence and necessity in myometrium during parturition . Science. 198:1977;958-960.
41. Puri C.P., Garfield R.E. Changes in hormone levels and gap junctions in the rat uterus during pregnancy and parturition. Biol Reprod. 27:1982;967-975.
42. Risek B., Guthrie S., Kumar N., Gilula N.B. Modulation of gap junction transcript and protein expression during pregnancy in the rat. J Cell Biol. 110:1990;269-282.
43. Lye S.J., Nicholson B.J., Mascarenhas M., MacKenzie L., Petrocelli T. Increased expression of connexin-43 in the rat myometrium during labor is associated with an increase in the plasma estrogen progesterone ratio . Endocrinology. 132:1993;2380-2386.
44. Geimonen E., Boylston E., Royek A., Andersen J. Elevated connexin-43 expression in term human myometrium correlates with elevated c-Jun expression and is independent of myometrial estrogen receptors. J Clin Endocrinol Metab. 83:1998;1177-1185.
45. Yamasaki H. Gap junctional intercellular communication and carcinogenesis. Carcinogenesis. 11:1990;1051-1058.
46. Ruch R.J. The role of gap junctional intercellular communication in neoplasia. Ann Clin Lab Sci. 24:1994;216-231.
47. Trosko J.E., Ruch R.J. Cell-cell communication in carcinogenesis. Front Biosci. 3:1998;D208-D236.
48. Bruni C. Abnormal cytodifferentiation in leiomyosarcomas induced with injection of nickel subsulfide into skeletal muscles of rats. Light and electron microscopic observations. Ann Clin Lab Sci. 16:1986;118-129.
49. Jone C., Trosko J.E., Chang C.C. Characterization of a rat liver epithelial cell line to detect inhibitors of metabolic cooperation. In Vitro Cell Dev Biol. 23:1987;214-220.